Efficacy of Alternative Dose Regimens of Exemestane in Postmenopausal Women With Stage 0 to II Estrogen Receptor-Positive Breast Cancer: A Randomized Clinical Trial. Davide Serrano , Sara Gandini , Parjhitham Thomas , Katherine D Crew , Nagi B Kumar , Lana A Vornik , J Jack Lee , Paolo Veronesi , Giuseppe Viale , Aliana Guerrieri-Gonzaga , Matteo Lazzeroni , Harriet Johansson , Mauro D'Amico , Flavio Guasone , Stefano Spinaci , Bjørn-Erik Bertelsen , Gunnar Mellgren , Isabelle Bedrosian , Diane Weber , Tawana Castile , Eileen Dimond , Brandy M Heckman-Stoddard , Eva Szabo , Powel H Brown , Andrea DeCensi , Bernardo Bonanni JAMA oncology（2023）
摘要
ClinicalTrials.gov Identifier: NCT02598557; EudraCT: 2015-005063-16.
更多 查看译文
AI 理解论文
溯源树
样例
